In our patient cohort, we found significantly more frequent somatic KRAS mutations in cervical adenocarcinoma, whereas PIK3CA mutations were more frequently found in squamous cell carcinoma (manuscript submitted). This evidence concerns the gene KRAS and cervical adenocarcinoma.